Scholarlink

<p>The use of fractional microporation to disrupt superficial skin is an effective approach to enhance drug absorption. This study analyzed and compared the effectiveness of fractional Er:YAG laser and radiofrequency microneedling (RM) in promoting skin penetration and hair follicle (HF) targeting of free or nanoencapsulated minoxidil and minocycline. Porcine skin delivery, with or without laser (3, 6, and 7&#xa0;mJ) and RM (6.1, 10.2, and 20.4&#xa0;mJ with a penetration depth of 0.5 or 1.0&#xa0;mm), was investigated using in vitro permeation test (IVPT). The in vitro and in vivo antibacterial activity of the microporation-assisted minocycline-loaded nanocarriers was also conducted. The skin deposition and flux of free minoxidil were increased by 3- and 56-fold, respectively, with laser treatment at 7&#xa0;mJ. The laser enhanced the deposition and flux of free minocycline by 25- and 40-fold compared to the untreated control, respectively. RM elevated the drug flux by 5‒18-fold compared to passive absorption. However, this enhancement effect was not observed in skin deposition. Nanostructured lipid carriers (NLC) and liposomes, with sizes of 81 and 76&#xa0;nm, were produced and entrapped approximately 80% of the drugs, respectively. Microporation increased skin delivery of nanoencapsulated drugs, though this enhancement was less pronounced than that of the free drugs. Biodistribution observed through confocal microscopy showed that microporation increased the penetration depth of lipid-based nanocarriers into the dermis compared to passive diffusion. The nanocarriers were primarily distributed into the microchannels and transported into the surrounding dermal tissue. Minocycline uptake in HF increased from 0.03 to 0.16 and 0.20&#xa0;nmol/cm<sup>2</sup> after the nanoencapsulation with NLC and liposomes, respectively. This uptake of NLC was further increased to 1.24 and 1.51&#xa0;nmol/cm<sup>2</sup> by laser and RM treatment. The minocycline-loaded nanocarriers inhibited <i>Cutibacterium acnes</i> viability in both planktonic and biofilm forms more effectively than the free drug. The in vivo <i>C. acnes</i> infection model in mice exhibited an efficient bacterial eradication through microporation-mediated nanocarrier delivery. The microchannel closure in laser- and RM-treated skin occurred within 36 and 12&#xa0;h, respectively, as indicated by transepidermal water loss (TEWL). These findings demonstrate that fractional laser and RM are promising strategies for improving skin- and HF-targeted absorption of nanoencapsulated drugs.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fractional microporation-guided delivery of nanoencapsulated drugs for enhanced cutaneous and follicular absorption: a comparison of ablative laser and radiofrequency microneedling

  • 期刊论文

  • 发表日期：

    2025年5月29日

查看全文
  • Woan-Ruoh Lee,
  • Ahmed Alalaiwe,
  • Meng-Tsan Tsai,
  • Sindy Hu,
  • Fang-Hsin Chang,
  • Min-Yu Chien,
  • Hsin-Ching Sung,
  • Jia-You Fang

摘要

The use of fractional microporation to disrupt superficial skin is an effective approach to enhance drug absorption. This study analyzed and compared the effectiveness of fractional Er:YAG laser and radiofrequency microneedling (RM) in promoting skin penetration and hair follicle (HF) targeting of free or nanoencapsulated minoxidil and minocycline. Porcine skin delivery, with or without laser (3, 6, and 7 mJ) and RM (6.1, 10.2, and 20.4 mJ with a penetration depth of 0.5 or 1.0 mm), was investigated using in vitro permeation test (IVPT). The in vitro and in vivo antibacterial activity of the microporation-assisted minocycline-loaded nanocarriers was also conducted. The skin deposition and flux of free minoxidil were increased by 3- and 56-fold, respectively, with laser treatment at 7 mJ. The laser enhanced the deposition and flux of free minocycline by 25- and 40-fold compared to the untreated control, respectively. RM elevated the drug flux by 5‒18-fold compared to passive absorption. However, this enhancement effect was not observed in skin deposition. Nanostructured lipid carriers (NLC) and liposomes, with sizes of 81 and 76 nm, were produced and entrapped approximately 80% of the drugs, respectively. Microporation increased skin delivery of nanoencapsulated drugs, though this enhancement was less pronounced than that of the free drugs. Biodistribution observed through confocal microscopy showed that microporation increased the penetration depth of lipid-based nanocarriers into the dermis compared to passive diffusion. The nanocarriers were primarily distributed into the microchannels and transported into the surrounding dermal tissue. Minocycline uptake in HF increased from 0.03 to 0.16 and 0.20 nmol/cm2 after the nanoencapsulation with NLC and liposomes, respectively. This uptake of NLC was further increased to 1.24 and 1.51 nmol/cm2 by laser and RM treatment. The minocycline-loaded nanocarriers inhibited Cutibacterium acnes viability in both planktonic and biofilm forms more effectively than the free drug. The in vivo C. acnes infection model in mice exhibited an efficient bacterial eradication through microporation-mediated nanocarrier delivery. The microchannel closure in laser- and RM-treated skin occurred within 36 and 12 h, respectively, as indicated by transepidermal water loss (TEWL). These findings demonstrate that fractional laser and RM are promising strategies for improving skin- and HF-targeted absorption of nanoencapsulated drugs.

Graphical Abstract